[1] Boothe JH, Morton J, Petisi JP, et al. Tetracycline [J]. J Am Chem Soc, 1953, 75: 4621.
[2] Dürckheimer W, Tetracycline: Chemistry, Biochemistry and Structure-activity Relation [M]. 14th Ed. New York: Angnew Chem Int., 1975, 721-774.
[3] Gabler WL, Smith J, Tsukuda N, et al. Comparison of doxycycline and a chemically modified inhibition of leukocyte function [J]. Res Commun Chem Pathol Pharmacol, 1992, 78: 151-160.
[4] Golub LM, Ramamurthyl NS, Liavaneras A, et al. A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats [J]. Ann NY Acad Sci, 1999, 878: 290-310.
[5] Golub LM, Lee HM, Ryan ME, et al. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms [J]. Adv Den Res, 1998, 12: 12-26.
[6] Tikka TM, Koistinaho J E. Minocycline provides neuroprotection against n-methyl-D-aspartate neurotoxicity by inhibition of microglia [J]. J Immunol, 2001, 166: 7527-7533.
[7] Tikka T, Fiebich BL, Goldsteins G, et al. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia [J]. J Neurosci, 2001, 21: 2580-2588.
[8] Trjänheikki J, Tikka T, Keinänen R, et al. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window [J]. Proc Natl Acad Sci USA, 1999, 96: 13496-13500.
[9] Trjänheikki J, Keinänen R, Pellilla M, et al. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia [ J]. Proc Natl Acad Sci USA, 1998, 95: 15769-15774.
[10] Rogalski W, Hlavka JJ, Boothe JH. The Tetracyclines in Handbook of Experimental Pharmacology [M]. 3nd Ed. Berlin: Springer-Verlag, 1985. 179-226.
[11] Du Y, Bales KR, Dodel RC, et al. Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons [ J]. Proc Natl Acad Sci USA, 1997, 94: 11657-11662.
[12] Du Y, Ma Z, Lin S, et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of parkinson’s disease [J]. Proc Natl Acad Sci USA, 2001, 98: 14669-14674. |
>
>